Chemiesynth board to meet on May 27 for Q4FY26 results
Chemiesynth (Vapi) Limited will hold a board meeting on May 27, 2026, to consider audited financial results for Q4 and FY26. The trading window is closed until 48 hours post-results announcement.

*this image is generated using AI for illustrative purposes only.
Chemiesynth (Vapi) Limited has announced that its board of directors will meet on Wednesday, May 27, 2026. The meeting is scheduled to take place at the company's registered office at 03:00 PM. The primary agenda includes the discussion and approval of the audited financial results for the quarter and fiscal year ended March 31, 2026.
Agenda for the Board Meeting
The board will deliberate on key financial documents and compliance requirements. The specific items listed for consideration include:
- To discuss, consider, approve, and take on record the Audited Financial Results of the Company for the quarter and year ended on March 31, 2026, along with the Auditor's report as per Regulation 33 of SEBI (LODR) Regulations, 2015.
- Any other items with the permission of the Chair and Majority of Directors.
Trading Window Closure
In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading, the trading window for the company's securities has been closed since Wednesday, April 1, 2026. The window will remain closed and shall reopen 48 hours after the declaration of the financial results.
Publication of Results
Following the board meeting, the audited financial results will be uploaded to the company's official website. An extract of the results will also be published in newspapers to ensure broad dissemination of the information to shareholders and the public.
Historical Stock Returns for Chemiesynth Vapi
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | +14.57% | +53.45% | +69.17% | +304.20% |
How might Chemiesynth (Vapi) Limited's FY2026 financial results compare to industry peers in the specialty chemicals sector, and what growth trajectory could investors expect going forward?
Following the trading window reopening, what potential stock price movement could be anticipated based on the company's historical post-results performance patterns?
Are there any planned capital expenditure or expansion initiatives that the board might announce alongside the FY2026 financial results that could signal future business direction?
































